Free Trial

Anixa Biosciences (ANIX) News Today

→ Elon to Transform U.S. Economy? (From Porter & Company) (Ad)
Free ANIX Stock Alerts
$2.55
+0.19 (+8.05%)
(As of 06/7/2024 08:51 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends
June 8 at 9:00 AM | insidertrades.com
Insider Buying: Anixa Biosciences, Inc. (NASDAQ:ANIX) CFO Acquires 6,250 Shares of Stock
June 7 at 1:26 PM | marketbeat.com
Anixa Biosciences, Inc. (NASDAQ:ANIX) CFO Michael Catelani Purchases 6,250 Shares
Anixa Biosciences, Inc. (NASDAQ:ANIX - Get Free Report) CFO Michael Catelani bought 6,250 shares of the firm's stock in a transaction that occurred on Friday, June 7th. The stock was purchased at an average price of $2.40 per share, with a total value of $15,000.00. Following the completion of the purchase, the chief financial officer now owns 35,211 shares in the company, valued at $84,506.40. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.
June 7 at 9:28 AM | americanbankingnews.com
Anixa Biosciences (NASDAQ:ANIX) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS
June 7 at 8:12 AM | americanbankingnews.com
Anixa Biosciences (NASDAQ:ANIX) Announces Earnings Results
June 7 at 7:39 AM | marketbeat.com
Anixa Biosciences (NASDAQ:ANIX) Announces Quarterly Earnings Results
Anixa Biosciences (NASDAQ:ANIX - Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.10) EPS for the quarter, topping analysts' consensus estimates of ($0.11) by $0.01.
June 1, 2024 | marketbeat.com
Anixa Biosciences, Inc. (NASDAQ:ANIX) Short Interest Down 12.3% in May
Anixa Biosciences, Inc. (NASDAQ:ANIX - Get Free Report) was the target of a large decrease in short interest in May. As of May 15th, there was short interest totalling 554,300 shares, a decrease of 12.3% from the April 30th total of 632,100 shares. Currently, 1.8% of the shares of the company are sold short. Based on an average daily volume of 111,000 shares, the short-interest ratio is presently 5.0 days.
May 28, 2024 | investorplace.com
7 Penny Biotech Stocks to Triple Your Investment
May 21, 2024 | finanznachrichten.de
Anixa Biosciences, Inc.: Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
May 21, 2024 | prnewswire.com
Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
May 8, 2024 | finanznachrichten.de
Anixa Biosciences, Inc.: Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
May 8, 2024 | msn.com
Anixa Biosciences enters JV with Cleveland Clinic for additional cancer vaccines
May 8, 2024 | markets.businessinsider.com
Anixa Inks Joint Development Agreement With Cleveland Clinic To Develop Novel Cancer Vaccines
May 8, 2024 | prnewswire.com
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
May 6, 2024 | prnewswire.com
Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja
April 30, 2024 | prnewswire.com
Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024
April 18, 2024 | finance.yahoo.com
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
April 11, 2024 | insidertrades.com
Lewis H. Titterton, Jr. Acquires 15,009 Shares of Anixa Biosciences, Inc. (NASDAQ:ANIX) Stock
April 10, 2024 | marketbeat.com
Anixa Biosciences, Inc. (NASDAQ:ANIX) Director Lewis H. Titterton, Jr. Buys 15,009 Shares
Anixa Biosciences, Inc. (NASDAQ:ANIX - Get Free Report) Director Lewis H. Titterton, Jr. acquired 15,009 shares of the firm's stock in a transaction dated Tuesday, April 9th. The stock was purchased at an average cost of $3.28 per share, with a total value of $49,229.52. Following the transaction, the director now owns 838,037 shares in the company, valued at $2,748,761.36. The purchase was disclosed in a legal filing with the SEC, which is available at this link.
March 22, 2024 | marketbeat.com
Anixa Biosciences, Inc. (NASDAQ:ANIX) to Post Q1 2025 Earnings of ($0.11) Per Share, HC Wainwright Forecasts
Anixa Biosciences, Inc. (NASDAQ:ANIX - Free Report) - Research analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for Anixa Biosciences in a report issued on Thursday, March 21st. HC Wainwright analyst Y. Chen anticipates that the company will post earnings of ($0.1
March 21, 2024 | marketbeat.com
Anixa Biosciences' (ANIX) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright restated a "buy" rating and issued a $12.00 price target on shares of Anixa Biosciences in a research report on Thursday.
March 18, 2024 | marketbeat.com
Anixa Biosciences, Inc. (NASDAQ:ANIX) Short Interest Up 8.2% in February
Anixa Biosciences, Inc. (NASDAQ:ANIX - Get Free Report) saw a large growth in short interest in the month of February. As of February 29th, there was short interest totalling 618,200 shares, a growth of 8.2% from the February 14th total of 571,500 shares. Approximately 2.1% of the shares of the company are short sold. Based on an average trading volume of 211,200 shares, the days-to-cover ratio is currently 2.9 days.
March 16, 2024 | finance.yahoo.com
ANIX Apr 2024 7.500 call
March 16, 2024 | finance.yahoo.com
ANIX Apr 2024 2.500 put
March 16, 2024 | insidertrades.com
Anixa Biosciences, Inc. (NASDAQ:ANIX) Director Buys $36,300.00 in Stock
March 15, 2024 | marketbeat.com
Anixa Biosciences, Inc. (NASDAQ:ANIX) Director Purchases $36,300.00 in Stock
Anixa Biosciences, Inc. (NASDAQ:ANIX - Get Free Report) Director Arnold M. Baskies purchased 10,000 shares of the firm's stock in a transaction that occurred on Friday, March 15th. The stock was bought at an average price of $3.63 per share, with a total value of $36,300.00. Following the transaction, the director now directly owns 110,000 shares in the company, valued at $399,300. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
March 14, 2024 | prnewswire.com
Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
March 12, 2024 | benzinga.com
Recap: Anixa Biosciences Q1 Earnings
March 11, 2024 | prnewswire.com
Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
February 22, 2024 | benzinga.com
Anixa Biosciences Stock (NASDAQ:ANIX) Insider Trades
February 21, 2024 | investing.com
Anixa Biosciences Inc (ANIX)
February 17, 2024 | finance.yahoo.com
We Think Anixa Biosciences (NASDAQ:ANIX) Can Easily Afford To Drive Business Growth
February 17, 2024 | finance.yahoo.com
ANIX Feb 2024 5.000 call
February 15, 2024 | marketbeat.com
Anixa Biosciences, Inc. Expected to Post FY2025 Earnings of ($0.40) Per Share (NASDAQ:ANIX)
Anixa Biosciences, Inc. (NASDAQ:ANIX - Free Report) - Analysts at HC Wainwright issued their FY2025 earnings estimates for Anixa Biosciences in a report issued on Tuesday, February 13th. HC Wainwright analyst Y. Chen expects that the company will earn ($0.40) per share for the year. HC Wainwright
February 13, 2024 | markets.businessinsider.com
Analysts Conflicted on These Healthcare Names: Anixa Biosciences (ANIX) and InMode (INMD)
February 13, 2024 | marketbeat.com
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Reaffirmed by HC Wainwright
HC Wainwright reissued a "buy" rating and issued a $12.00 price target on shares of Anixa Biosciences in a report on Tuesday.
February 12, 2024 | finanznachrichten.de
Anixa Biosciences, Inc.: Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial
February 12, 2024 | finance.yahoo.com
Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial
February 6, 2024 | finance.yahoo.com
3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023
January 30, 2024 | ca.finance.yahoo.com
Dogs Can Suffer from Depression — Here Are Signs to Look Out for and How to Diagnosis Them
January 30, 2024 | msn.com
Here’s Why You Get a Runny Nose When You’re Eating
January 30, 2024 | ca.news.yahoo.com
Visible wants to track your illness, more than your fitness
January 30, 2024 | ca.finance.yahoo.com
Recalled cinnamon applesauce pouches were never tested for lead, FDA reports
January 30, 2024 | ca.style.yahoo.com
If You Suffer From Intense PMS, This Condition Could Be The Cause
January 30, 2024 | ca.style.yahoo.com
King Charles smiles as he leaves hospital following prostate procedure
January 30, 2024 | msn.com
Kristen Dahlgren: Why I’m leaving NBC to launch a nonprofit to make breast cancer vaccines a reality
January 29, 2024 | marketbeat.com
Anixa Biosciences, Inc. (NASDAQ:ANIX) Short Interest Up 10.7% in January
Anixa Biosciences, Inc. (NASDAQ:ANIX - Get Free Report) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 670,900 shares, a growth of 10.7% from the December 31st total of 606,100 shares. Approximately 2.2% of the company's shares are short sold. Based on an average daily volume of 183,400 shares, the days-to-cover ratio is currently 3.7 days.
January 29, 2024 | finance.yahoo.com
Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference
January 23, 2024 | msn.com
Anixa ovarian cancer vaccine tech gets Japanese patent
January 23, 2024 | finanznachrichten.de
Anixa Biosciences, Inc.: Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
January 23, 2024 | finance.yahoo.com
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
Get Anixa Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter.

It's time to ween off Chinese lithium! (Ad)

As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely

Learn how this American company is leading the lithium-ion revolution

ANIX Media Mentions By Week

ANIX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ANIX
News Sentiment
▼
1.35

0.76
▲
Average
Medical
News Sentiment

ANIX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ANIX Articles
This Week
▼
8

2
▲
ANIX Articles
Average Week

Get Anixa Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:ANIX) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners
Write this ticker symbol down…
A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...
StocksToTrade | Sponsored
It's time to ween off Chinese lithium!
As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...
Smallcaps Daily | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
The Only Energy Play You Should Be Looking At
Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...
Wealthpin Pro | Sponsored
You won't believe what Citigroup just did to it's depositors
The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...
American Alternative | Sponsored
RSVP: Charles Payne’s Cash Flow Workshop
Did you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...
Unstoppable Prosperity | Sponsored